Lesser doses for perioral treatment than for upper facial programs are employed because the oral musculature responds much more strongly to the identical BTX-A dosing. Just one preparation of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indicator and FDA approval lies in treatments of cervical dystonia. Moreover, Botox https://steven148aip0.blog-gold.com/profile